Literature DB >> 21116745

Phytochemicals in the oncology setting.

Catherine E Ulbricht1, Wendy Chao.   

Abstract

Phytochemicals--the bioactive compounds found in plants--not only hold historical significance in various medical traditions, but also form the basis of many modern-day drugs. Phytochemicals are often used for primary disease prevention or as adjuncts to conventional therapies--despite uncertain effectiveness or safety. On the other hand, phytochemicals have given rise to numerous conventional drugs, which are widely used in mainstream medicine and compose the primary therapeutic strategies for numerous conditions (including cancer). In this review, we will discuss general safety considerations for integrating phytochemicals in the oncology setting. The supportive evidence and safety concerns of popular plant-based cancer therapies will also be summarized. Finally, a brief overview of the established and emerging anticancer drugs with botanical origins will be provided.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116745     DOI: 10.1007/s11864-010-0130-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  55 in total

Review 1.  Wine, resveratrol and health: a review.

Authors:  Raúl F Guerrero; Maria C García-Parrilla; Belén Puertas; Emma Cantos-Villar
Journal:  Nat Prod Commun       Date:  2009-05       Impact factor: 0.986

2.  Alternative medicine remedies might stimulate viability of leukemic cells.

Authors:  Jan Styczynski; Mariusz Wysocki
Journal:  Pediatr Blood Cancer       Date:  2006-01       Impact factor: 3.167

3.  Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.

Authors:  R Grossarth-Maticek; Renatus Ziegler
Journal:  Eur J Med Res       Date:  2006-11-30       Impact factor: 2.175

4.  The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate.

Authors:  Patrick Smith; Julie M Bullock; Brent M Booker; Curtis E Haas; Charles S Berenson; William J Jusko
Journal:  Pharmacotherapy       Date:  2004-11       Impact factor: 4.705

Review 5.  Silibinin--a promising new treatment for cancer.

Authors:  Catherine Wing Ying Cheung; Norma Gibbons; David Wayne Johnson; David Lawrence Nicol
Journal:  Anticancer Agents Med Chem       Date:  2010-03       Impact factor: 2.505

6.  Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.

Authors:  Timothy L Ramsey; Kelly E Risinger; Sarah C Jernigan; Kathleen A Mattingly; Carolyn M Klinge
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

7.  Intake of beer, wine, and spirits and risk of stroke : the copenhagen city heart study.

Authors:  T Truelsen; M Gronbaek; P Schnohr; G Boysen
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

Review 8.  Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials.

Authors:  Nathalie Druesne-Pecollo; Paule Latino-Martel; Teresa Norat; Emilie Barrandon; Sandrine Bertrais; Pilar Galan; Serge Hercberg
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

9.  The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.

Authors:  V F Semiglasov; V V Stepula; A Dudov; W Lehmacher; U Mengs
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

10.  Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.

Authors:  Encouse B Golden; Philip Y Lam; Adel Kardosh; Kevin J Gaffney; Enrique Cadenas; Stan G Louie; Nicos A Petasis; Thomas C Chen; Axel H Schönthal
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

View more
  6 in total

Review 1.  The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors.

Authors:  Roy E Strowd; Stuart A Grossman
Journal:  Curr Treat Options Oncol       Date:  2015-08

2.  Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract.

Authors:  Sushma R Gundala; Rao Mukkavilli; Chunhua Yang; Pooja Yadav; Vibha Tandon; Subrahmanyam Vangala; Satya Prakash; Ritu Aneja
Journal:  Carcinogenesis       Date:  2014-01-15       Impact factor: 4.944

3.  Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation.

Authors:  Meera Brahmbhatt; Sushma R Gundala; Ghazia Asif; Shahab A Shamsi; Ritu Aneja
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

4.  Anticancer activity of taraxerol acetate in human glioblastoma cells and a mouse xenograft model via induction of autophagy and apoptotic cell death, cell cycle arrest and inhibition of cell migration.

Authors:  Jing-Fang Hong; Ying-Fang Song; Zheng Liu; Zhao-Cong Zheng; Hong-Jie Chen; Shou-Sen Wang
Journal:  Mol Med Rep       Date:  2016-04-12       Impact factor: 2.952

Review 5.  In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment.

Authors:  Massimo Fantini; Monica Benvenuto; Laura Masuelli; Giovanni Vanni Frajese; Ilaria Tresoldi; Andrea Modesti; Roberto Bei
Journal:  Int J Mol Sci       Date:  2015-04-24       Impact factor: 5.923

6.  Surfactin from Bacillus subtilis induces apoptosis in human oral squamous cell carcinoma through ROS-regulated mitochondrial pathway.

Authors:  Thi Thuy Tien Vo; Ju-Fang Liu; Ching-Zong Wu; Wei-Ning Lin; Yuh-Lien Chen; I-Ta Lee
Journal:  J Cancer       Date:  2020-10-21       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.